Published in Oncotarget on June 10, 2015
The Functional Analysis of Histone Acetyltransferase MOF in Tumorigenesis. Int J Mol Sci (2016) 0.83
Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy. World J Gastrointest Oncol (2015) 0.75
The NSL Chromatin-Modifying Complex Subunit KANSL2 Regulates Cancer Stem-like Properties in Glioblastoma That Contribute to Tumorigenesis. Cancer Res (2016) 0.75
Structure and function of histone acetyltransferase MOF. AIMS Biophys (2015) 0.75
Signal transduction by the JNK group of MAP kinases. Cell (2000) 18.24
JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell (1994) 16.30
AP-1 as a regulator of cell life and death. Nat Cell Biol (2002) 10.10
Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev (1993) 10.01
AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer (2003) 8.88
The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell (1988) 7.76
Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc (2006) 6.24
AP-1 in cell proliferation and survival. Oncogene (2001) 6.07
Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem (1991) 5.48
Covalent modifications of histones during development and disease pathogenesis. Nat Struct Mol Biol (2007) 4.17
Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell (2003) 3.92
Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev (1999) 3.51
Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science (1997) 3.11
The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol (1991) 3.08
Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J (2000) 2.66
c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev Cell (2003) 2.59
Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci U S A (1999) 2.43
Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex. J Biol Chem (2009) 2.23
The mammalian Jun proteins: redundancy and specificity. Oncogene (2001) 2.13
Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene (1996) 2.00
Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J Natl Cancer Inst (2004) 2.00
Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J (2002) 2.00
A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J (2003) 1.83
The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell (2000) 1.81
The nonspecific lethal complex is a transcriptional regulator in Drosophila. Mol Cell (2010) 1.68
JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J (2003) 1.67
JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell (2007) 1.56
MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence. Nat Cell Biol (2004) 1.51
AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol Cell Biol (1997) 1.46
c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex. Nature (2011) 1.39
Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation. Cell Signal (2013) 1.35
The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription. EMBO J (2002) 1.30
The MOF-containing NSL complex associates globally with housekeeping genes, but activates only a defined subset. Nucleic Acids Res (2011) 1.13
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma. Cancer Res (2007) 1.13
Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction. Oncogene (2003) 1.10
Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters. Eur J Gynaecol Oncol (2006) 1.05
DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway. Cancer Res (2008) 1.04
Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression. Proc Natl Acad Sci U S A (2001) 1.02
Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation. Proc Natl Acad Sci U S A (2012) 0.96
Mof-associated complexes have overlapping and unique roles in regulating pluripotency in embryonic stem cells and during differentiation. Elife (2014) 0.92
Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma. Mol Carcinog (2007) 0.84
STAT2 phosphorylation and signaling. JAKSTAT (2013) 0.81
The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene (1997) 0.79
Acetylation regulates Jun protein turnover in Drosophila. Biochim Biophys Acta (2013) 0.77